Globus Medical (GMED) : During the past 4 weeks, traders have been relatively bearish on Globus Medical (GMED), hence the stock is down -5.33% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.21% relative to the S&P 500. The 4-week change in the price of the stock is -5.84% and the stock has fallen -0.04% in the past 1 week.
The stock has recorded a 20-day Moving Average of 1.55% and the 50-Day Moving Average is 2.72%.The 200 Day SMA reached 6.7%
Globus Medical (NYSE:GMED): After opening at $22.43, the stock dipped to an intraday low of $22.23 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $22.69 and the buying power remained strong till the end. The stock closed at $22.57 for the day, a gain of 0.98% for the day session. The total traded volume was 730,301. The stocks close on the previous trading day was $22.57.
Globus Medical (GMED) : The consensus price target for Globus Medical (GMED) is $26.5 for the short term with a standard deviation of $3.34. The most optimist securities analyst among the 8 who monitor the stock believes that the stock can reach $33, however, the pessimist price target for the company is $23.
Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders and spine disorders. Its products consist of two categories: Innovative Fusion and Disruptive Technologies. Innovative Fusion products comprise fusion products to treat various spinal disorders for the entire spine and can be used in various surgical approaches. Disruptive Technologies represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. The Companys portfolio of Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques, as well as treatment alternatives, including motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and biomaterials technologies, as well as interventional pain management solutions.